The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[(4-oxo-2-phenyl-3,5,7,8-tetrahydropyrido[4,3-d]pyrimidin-6(4H)-yl)carbonyl]benzenesulfonamide ID: ALA4540574
PubChem CID: 155549634
Max Phase: Preclinical
Molecular Formula: C20H18N4O4S
Molecular Weight: 410.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)c1ccc(C(=O)N2CCc3nc(-c4ccccc4)[nH]c(=O)c3C2)cc1
Standard InChI: InChI=1S/C20H18N4O4S/c21-29(27,28)15-8-6-14(7-9-15)20(26)24-11-10-17-16(12-24)19(25)23-18(22-17)13-4-2-1-3-5-13/h1-9H,10-12H2,(H2,21,27,28)(H,22,23,25)
Standard InChI Key: FLKMCUCHEIMTPR-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
44.9992 -4.4863 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.5947 -3.7805 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
44.1857 -4.4837 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.1201 -3.7805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1189 -4.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8270 -5.0090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5366 -4.5996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5338 -3.7769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8252 -3.3716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2400 -3.3656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9466 -3.7738 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9427 -2.1404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2324 -2.5498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9424 -1.3232 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.6518 -2.5485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6502 -3.3680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3553 -3.7768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0663 -3.3706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0678 -2.5511 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.3583 -2.1378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7767 -2.1446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4832 -2.5552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7790 -1.3274 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.4765 -3.3730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1822 -3.7835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1855 -2.1486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8918 -2.5555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8884 -3.3735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3038 -3.3746 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 2 0
10 13 1 0
11 16 1 0
15 12 1 0
12 13 1 0
12 14 2 0
15 16 2 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
19 21 1 0
21 22 1 0
21 23 2 0
22 24 2 0
24 25 1 0
25 28 2 0
27 26 2 0
26 22 1 0
27 28 1 0
28 2 1 0
2 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 410.46Molecular Weight (Monoisotopic): 410.1049AlogP: 1.28#Rotatable Bonds: 3Polar Surface Area: 126.22Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.98CX Basic pKa: 0.40CX LogP: 0.59CX LogD: 0.50Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.67Np Likeness Score: -1.63
References 1. Kawai J, Ota M, Ohki H, Toki T, Suzuki M, Shimada T, Matsui S, Inoue H, Sugihara C, Matsuhashi N, Matsui Y, Takaishi S, Nakayama K.. (2019) Structure-Based Design and Synthesis of an Isozyme-Selective MTHFD2 Inhibitor with a Tricyclic Coumarin Scaffold., 10 (6): [PMID:31223444 ] [10.1021/acsmedchemlett.9b00069 ]